Key facts
- It has raised $28.3M; the latest was PE Growth/Expansion ($28.3M) in Jan 2025.
- Notable investors include NextStage AM.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Evoluderm
- ·The full record, as it builds
Funding rounds
No funding rounds for Evoluderm are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Evoluderm
Manufacturer of skincare and hygiene products intended for adults and babies. The company offers hydrating, cleansing, nourishing, purifying, and soothing products for skin and hair, enabling customers to get cosmetic solutions made by natural and vegan ingredients.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Gennevilliers, France
- Founded
- 2004
- Employees
- 47
- Website
- evoluderm.com/
- Ownership
- Privately Held (backing)
Evoluderm doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Evoluderm shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Evoluderm in its N-PORT filings yet. We sweep new filings monthly.